Novartis Pharmaceuticals Senior Marketing Manager Salaries in Boulder
The average Novartis Pharmaceuticals Senior Marketing Manager in Boulder earns an estimated $154,584 annually, which includes an estimated base salary of $135,834 with a $18,750 bonus. Novartis Pharmaceuticals' Senior Marketing Manager compensation is $27,227 more than the US average for a Senior Marketing Manager. Senior Marketing Manager salaries at Novartis Pharmaceuticals in Boulder can range from $121,000 - $251,000.
In Boulder, The Marketing Department at Novartis Pharmaceuticals earns $2,052 more on average than the Communications Department.
Last updated 2 years ago.
- $135,834
- avg. base
- $18,750
- avg. bonus
Senior Marketing Manager Salaries at Novartis Pharmaceuticals
In Boulder, Senior Marketing Managers earn $3,623 more than Global Marketing Managers, and $293 less than Senior Marketing Managers.
Compensation at Novartis Pharmaceuticals by Department
In Boulder, The Marketing Department averages $2,052 more than the Communications Department, and $8,922 less than the Design Department
Senior Marketing Manager Compensation by Gender (All Companies)
The average female Senior Marketing Manager at companies similar size to Novartis Pharmaceuticals reported making $147,184, while the average male Senior Marketing Manager at similar sized companies reported making $167,339.
Senior Marketing Manager Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Senior Marketing Manager at companies similar size to Novartis Pharmaceuticals reported making $169,506, while the average Native American Senior Marketing Manager at similar sized companies reported making $130,000.
How Senior Marketing Managers at Novartis Pharmaceuticals Rate Their Compensation
The majority of Senior Marketing Managers at Novartis Pharmaceuticals believe they're compensated fairly. 100% of Senior Marketing Managers at Novartis Pharmaceuticals say they receive annual bonuses, and the vast majority (79%) are satisfied with their benefits. See more compensation ratings at Novartis Pharmaceuticals
